Nika Pharmaceuticals Files Q1 2025 10-Q
Ticker: NIKA · Form: 10-Q · Filed: May 13, 2025 · CIK: 1145604
| Field | Detail |
|---|---|
| Company | Nika Pharmaceuticals, Inc (NIKA) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
NIKA PHARMACEUTICALS FILED ITS Q1 2025 10-Q. FINANCIALS ARE OUT.
AI Summary
Nika Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q for the period ending March 31, 2025. The company, previously known as Centennial Growth Equities Inc., is based in Henderson, Nevada. The filing details financial information for the first quarter of 2025 and comparative periods.
Why It Matters
This filing provides investors with an update on Nika Pharmaceuticals' financial performance and position as of March 31, 2025, crucial for assessing the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new disclosures.
Key Numbers
- Q1 2025 — Reporting Period (Financials for the first quarter of 2025 are detailed.)
- 2025-03-31 — As of Date (The financial position reported is as of this date.)
Key Players & Entities
- NIKA PHARMACEUTICALS, INC (company) — Filer
- CENTENNIAL GROWTH EQUITIES INC (company) — Former company name
- 20250331 (date) — Reporting period end date
- 20250513 (date) — Filing date
- 7023263615 (phone_number) — Business phone number
FAQ
What is Nika Pharmaceuticals' primary business activity?
Nika Pharmaceuticals, Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]' according to its Standard Industrial Classification.
When was the company formerly known as Centennial Growth Equities Inc.?
The date of the name change from Centennial Growth Equities Inc. to Nika Pharmaceuticals, Inc. was July 24, 2001.
Where is Nika Pharmaceuticals, Inc. located?
The company's business and mailing address is 2269 Merrimack Valley Avenue, Henderson, NV 89044.
What is the SEC file number for Nika Pharmaceuticals?
The SEC file number for Nika Pharmaceuticals, Inc. is 000-56234.
What period does this 10-Q filing cover?
This Form 10-Q covers the period ending March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding NIKA PHARMACEUTICALS, INC (NIKA).